Advertisement

Topics

Microreactor Technology Adoption to Spur as an Optimal Time-to-Market Enabler and Effective Solution in Pharmaceutical Drug Synthesis

05:30 EST 20 Feb 2019 | Lab Bulletin

A recent research study by Fact.MR finds that the microreactor sales reached approximately 294 thousand units in 2018 and are projected to grow at a Y-O-Y of nearly 9% in 2019. Increasing competition among manufacturers to develop efficient products remains a key aspect spurring the demand for microreactor technology. Enablement in facilitating effective and efficient drug synthesis is one of the key factors responsible for rising adoption in the pharmaceutical industry....

Original Article: Microreactor Technology Adoption to Spur as an Optimal Time-to-Market Enabler and Effective Solution in Pharmaceutical Drug Synthesis

NEXT ARTICLE

More From BioPortfolio on "Microreactor Technology Adoption to Spur as an Optimal Time-to-Market Enabler and Effective Solution in Pharmaceutical Drug Synthesis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...